Nanna Holt Jessen

Dr. Nanna Holt Jessen

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2012 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
HSHalfdan Sorbye
Halfdan Sorbye
SWS. Welin
S. Welin
SLS. W. Langer
S. W. Langer
LVL. W. Vestermark
L. W. Vestermark
NJNanna Holt Jessen
Nanna Holt Jessen
UKU. Knigge
U. Knigge
As studies on gastrointestinal neuroendocrine carcinoma (WHO G3) (GI-NEC) are limited, we reviewed clinical data to identify predictive and prognostic markers for advanced GI-NEC patients. Data from advanced GI-NEC patients diagnosed 2000–2009 were retrospectively registered at 12 Nordic hospitals. The median survival was 11 months in 252 patients given palliative chemotherapy and 1 month in 53 patients receiving best supportive care (BSC) only. The response rate to first-line chemotherapy was 31% and 33% had stable disease. Ki-67 < 55% was by receiver operating characteristic analysis the best cut-off value concerning correlation to the response rate. Patients with Ki-67 < 55% had a lower response rate (15% versus 42%, P < 0.001), but better survival than patients with Ki-67 ≥ 55% (14 versus10 months, P < 0.001). Platinum schedule did not affect the response rate or survival. The most important negative prognostic factors for survival were poor performance status (PS), primary colorectal tumors and elevated platelets or lactate dehydrogenase (LDH) levels. Advanced GI-NEC patients should be considered for chemotherapy treatment without delay.PS, colorectal primary and elevated platelets and LDH levels were prognostic factors for survival. Patients with Ki-67 < 55% were less responsive to platinum-based chemotherapy, but had a longer survival. Our data indicate that it may not be correct to consider all GI-NEC as one single disease entity.

14 January 2013 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
NJNanna Holt Jessen
Nanna Holt Jessen
Henning GrønbækHenning Grønbæk
Henning Grønbæk
Goblet cell carcinoid (GCC) tumors are a rare subgroup of neuroendocrine tumors almost exclusively originating in the appendix. The tumor most often presents in the fifth or sixth decade with a clinical picture of appendicitis or in advanced cases an abdominal mass associated with abdominal pain. Histologically tumors are most often positive for chromogranin A and synaptophysin, however, less homogenous than for classic appendix carcinoids. The malignant potential is higher than that for the classic appendix carcinoids due to local spread and distant metastases at diagnosis and the proliferation markers (Ki67 index) may determine prognosis. Octreotide receptor scintigraphy is usually negative while CT/MRI scans may be useful. Chromogranin A is usually negative and other biomarkers related to the mucinous component or the tumor (CEA, CA‐19‐9, and CA‐125) may be used. Surgery is the main treatment with appendectomy and right hemicolectomy while patients with disseminated disease should be treated with chemotherapy. Overall 5‐year survival is approximately 75%. The diagnosis and treatment of GCC tumorss should be restricted to high volume NET centers in order to accumulate knowledge and improve survival in GCC NET patients. The aim of this paper is to update on epidemiology, clinical presentation, and diagnostic markers including Ki67 index, treatment, and survival.

11 February 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IOIngrid Holst Olsen
Ingrid Holst Olsen
NJNanna Holt Jessen
Nanna Holt Jessen
SLSeppo W Langer
Seppo W Langer
JHJane P Hasselby
Jane P Hasselby
Henning GrønbækHenning Grønbæk
Henning Grønbæk
UKUlrich Knigge
Ulrich Knigge
Appendiceal goblet cell carcinoids (GCCs) exhibit neuroendocrine and adenocarcinoma features. Analysis of demography, pathology, prognostic markers, treatment and survival in 83 GCC patients (f/m: 56/27) diagnosed 1992-2013. Median age for f/m was 59/58 years, respectively, and similar for localized and disseminated disease. At diagnosis 54 patients had localized appendiceal disease (f/m: 29/25). According to TNM 24% had Stage I, 70% had Stage II and 6% had Stage III. Twenty-nine patients had disseminated disease (f/m: 27/2). Chromogranin A, synaptophysin and p53 were positive in >90%. Serotonin was positive in 70%. Median Ki67 index was 32% (6-75%) and higher in Tang group C (50%) compared to group A (30%; p<0.0001), and group B (30%; p<0.004). All patients had surgery. Sixty-three (76%) had radical resections including all patients with localized disease. Median OS was 83 months. The 1-, 5- and 10-year survival rates were 90%, 58%, and 38%, respectively. For localized disease OS was 164 months and 1-, 5- and 10-year survival rates were 100%, 80%, and 55%, respectively. For disseminated disease OS was 19 months and 1-, 5- and 10-year survival rates were 73%, 18% and 6%, respectively. The 1-, 5- and 10 year-survival rates for f/m were 87%/96%, 49%/76% and 31%/57%, respectively (p = 0.02). According to the Tang classification group A, B, and C OS was 118, 83 and 20 months, respectively (p = 0.0002). The Tang classification was found to be a significant prognostic factor, while the Ki67 index was not. Localized GCCs occurred equally in males and females, while disseminated GCCs were mostly seen in females. Median age of patients with localized disease and disseminated disease was identical. Cox regression analysis found Stage IV, focally positive synaptophysin and non-radical surgery as strongest negative prognostic factors.

24 July 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
NJNanna Holt Jessen
Nanna Holt Jessen
CLClaus Løvschall
Claus Løvschall
SSSebastian Skejø
Sebastian Skejø
LMLouise Sofia Madsen
Louise Sofia Madsen
SCSus Sola Corazon
Sus Sola Corazon
DPDorthe Varning Poulsen
Dorthe Varning Poulsen
Objectives The use of natural environments and nature activities as elements in the treatment and rehabilitation of mental health challenges is gaining international attention. The objective of the present review was to summarise the knowledge on the effects of nature-based health interventions (NBHIs) targeting individuals diagnosed with anxiety, depression and/or experiencing stress. Design Systematic review and meta-analyses. The quality and certainty of evidence were assessed using the SIGN and GRADE. Data sources Searches were performed in Embase, MEDLINE, PsycINFO, CINAHL, Cochrane and Web of Science. Eligibility criteria (1) NBHIs, (2) Individuals with a diagnosis of mild to moderate anxiety, depression and/or experiencing stress, (3) Age of participating individuals: 18–84 years, (4) Study designs: randomised controlled trials, cohort studies, case-control studies and case-series studies and (5) Publication date: 2000–2024. Data extraction and synthesis Screening, quality appraisal and certainty of evidence, assessed using SIGN and GRADE, were performed by two independent reviewers, except title screening. Meta-analyses were performed using random-effect models. Results Nineteen articles were included, of which 14 were included in the meta-analyses. The articles showed substantial variation in design, interventions, settings and risk of bias, limiting the certainty of evidence according to GRADE. Participating in NBHIs led to a small to large effect in mental health with standardised mean changes of −0.80 (95% CI= (−1.56; −0.04)), −0.87 (95% CI= (−1.18; −0.56)), −0.32 (95% CI= (−0.74; 0.09)) and 0.58 (95% CI= (0.39; 0.77)) for anxiety, depression and stress scores and overall mental health scores, respectively. Conclusions This is the first systematic review examining the effect of NBHIs exclusively on individuals diagnosed with anxiety, depression and/or experiencing stress. Our findings suggest small to large improvements after participating in NBHIs. However, methodological limitations to the included articles necessitate cautious interpretation. PROSPERO registration number CRD42024516270.

27 April 2021 in Family Practice
Verified
Journal Article
Open access
PDF file
NJNanna Holt Jessen
Nanna Holt Jessen
HJHenry Jensen
Henry Jensen
CHCharles W Helsper
Charles W Helsper
AFAlina Z Falborg
Alina Z Falborg
HGHenning Glerup
Henning Glerup
PVPeter Vedsted
Peter Vedsted
Background: Abdominal cancers represent 30% of all diagnosed cancers. Nevertheless, it is unknown if the general practitioner’s (GP’s) initial cancer suspicion varies for different abdominal cancer types and how this is associated with referrals to standardized cancer patient pathways (CPPs). Objectives: To explore initial cancer suspicion in GPs and to investigate how this was associated with GP referrals to CPPs and the duration of the primary care interval (PCI) in 10 different abdominal cancer types. Methods: We conducted a cohort study on 1104 incident abdominal cancer patients diagnosed in Denmark in 2016 using a combination of survey and register-based data. Poisson regression was used to estimate associations between GP cancer suspicion, CPP referral and PCI duration. Results: The GPs initially suspected cancer or other serious disease in 46–78% of cases, lowest in kidney cancer, and referred 35–65% to a CPP, lowest in oesophageal cancer. The GP’s suspicion at the first presentation was strongly associated with referral to a CPP. The median (0–11 days) and 75th percentile (3–32 days) PCIs varied between the abdominal cancer types. The likelihood of a long PCI was more than 3-fold higher when the GP did not initially suspect cancer. Conclusion: In up to half of abdominal cancer patients, there is no initial suspicion of cancer or serious disease. CPPs were used in only one-third to two-thirds of patients, depending on cancer type. For kidney cancer, as well as several abdominal cancers, we need better diagnostic strategies to support GPs to enable effective and efficient referral.

1 January 2025 in Health & Social Care in the Community
Verified
Journal Article
Open access
JJJulie Sandell Jacobsen
Julie Sandell Jacobsen
RNRasmus Østergaard Nielsen
Rasmus Østergaard Nielsen
NJNanna Holt Jessen
Nanna Holt Jessen
HSHalfdan Thorsø Skjerning
Halfdan Thorsø Skjerning
SSSebastian Skejø
Sebastian Skejø
KRKnud Ryom
Knud Ryom
Background: Social prescribing (SP) has received increasing interest in recent years due to its potential to encourage health‐promoting behaviours, such as physical activity (PA). However, to develop effective SP interventions, it is critical to enhance our understanding of the mechanisms of change associated with SP and their potential to promote PA. This review aimed to synthesise the mechanisms of change in SP interventions and to develop a logic model illustrating a theoretical framework for SPs potential to promote PA. Methods: A narrative review was performed, including a systematic literature search in Medline, Embase and PsycINFO. The systematic literature search was finalised on 21 February 2023, and studies investigating mechanisms of change in SP interventions were included. Findings were synthesised and illustrated in a logic model illustrating how SP interventions may promote PA as an outcome. Results: The systematic literature search identified 340 studies, of which 11 met the inclusion criteria. The SP interventions comprised three processes: referral, linking and engagement. These processes influenced various mechanisms of change, which were classified into two perspectives. From a person‐centred perspective, the mechanisms with the potential to promote PA comprised self‐efficacy, motivation, empowerment and ‘having a voice’. These mechanisms were associated with crucial elements of SP, such as tailoring to needs, trusted relationships, nonstigmatising activities and peer‐to‐peer support. From a system‐based perspective, the mechanisms with the potential to promote PA included system capacity and resources together with shared understanding and knowledge. These mechanisms were related to crucial elements of SP, including reliance on established communication and network, local agency and accessibility. Conclusion: A person‐centred perspective describes SPs potential to promote PA through various mechanisms of change. However, these mechanisms appear to be intricately connected with the local context. Consequently, SP intervention research could benefit from incorporating contextual factors and, ideally, also integrating system thinking.